Drive to Inhibit 'Master Switch' for Tumor Embryonic Growth
By Sharon Kingman
Tuesday, February 26, 2013
LONDON Identification of a protein that orchestrates many of the changes that permit a normal cell to turn into a cancer cell will open up an entirely new field of cancer therapeutics, the researchers who made the discovery predicted. The team, from ICREA in Barcelona, Spain, also established a screening system to identify compounds that will inhibit the protein.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.